GGrantIndex
← Leaderboards

James Craig Forrest

Emory University

$8,000,159
Attributed
$8,968,660
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,968,660 · 8

By mechanism

R01$5,906,829 · 3
P20$1,635,968 · 1
R21$859,961 · 2
R56$525,786 · 1
P51$40,116 · 1

Top collaborators

Others in their field

Top investigators on “Virus

Research focus

VirusInfectionPathogenesisCellsViralHuman Herpesvirus 8PublishingViral ProteinsMalignant NeoplasmsPathogenPreventGammaherpesvirusAnimal ModelProteinsTumorigenesisRodentIn VivoCell TypeLymphocyteDna Tumor VirusesIncidenceChronicHuman Herpesvirus 4Viral Genes

Grant awards (28)

Defining KSHV LANA functions in viral pathogenesis and immune evasion$477,807
R01 · FY2025 · AI · contact PI
Lytic viral genes in the pathogenesis of oncogenic gammaherpesviruses$420,335
R21 · FY2025 · AI · contact PI
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$367,611
R01 · FY2025 · CA · contact PI
Defining KSHV LANA functions in viral pathogenesis and immune evasion$488,841
R01 · FY2024 · AI · contact PI
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$349,383
R01 · FY2024 · CA · contact PI
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$59,432
R01 · FY2024 · CA · contact PI
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$360,565
R01 · FY2023 · CA · contact PI
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients$324,563
R01 · FY2023 · CA
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$62,560
R01 · FY2023 · CA · contact PI
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients$372,415
R01 · FY2022 · CA
Defining mechanisms of gammaherpesvirus-driven genomic instability in B cells$368,072
R01 · FY2022 · CA · contact PI
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients$372,400
R01 · FY2021 · CA
Defining mechanisms of KSHV pathogenesis using MHV68-KSHV chimeric viruses$525,786
R56 · FY2020 · AI · contact PI
Defining the efficacy of replication-dead viruses as gammaherpesvirus vaccines$233,250
R21 · FY2020 · AI · contact PI
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients$70,205
R01 · FY2020 · CA
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients$377,084
R01 · FY2019 · CA
Defining the efficacy of replication-dead viruses as gammaherpesvirus vaccines$206,376
R21 · FY2019 · AI · contact PI
Gammaherpesvirus interactions with host tumor suppressor p53$359,998
R01 · FY2018 · CA · contact PI
Gammaherpesvirus interactions with host tumor suppressor p53$384,981
R01 · FY2017 · CA · contact PI
Gammaherpesvirus interactions with host tumor suppressor p53$359,998
R01 · FY2016 · CA · contact PI
Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis$329,500
P20 · FY2016 · GM · contact PI
Gammaherpesvirus interactions with host tumor suppressor p53$390,916
R01 · FY2015 · CA · contact PI
Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis$329,500
P20 · FY2015 · GM · contact PI
Gammaherpesvirus interactions with host tumor suppressor p53$359,998
R01 · FY2014 · CA · contact PI
Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis$329,500
P20 · FY2014 · GM · contact PI
Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis$317,968
P20 · FY2013 · GM · contact PI
Project 1 - Virus-Host Interactions in Gammaherpesvirus Pathogenesis$329,500
P20 · FY2012 · GM · contact PI
DETERMINANTS OF CHRONIC GAMMAHERPESVIRUS 68 INFECTION$40,116
P51 · FY2006 · RR · contact PI